Risk factors


Dec. 24, 2015
  1. Beekwilder JP, et al. Overview of the clinical applications of vagus nerve stimulation. Journal of Clinical Neurophysiology. 2010;27:130.
  2. Morris, GL, et al. Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013; 81:1453.
  3. Chengyuan Wu, et al. Neurostimulation for the treatment of epilepsy: A review of current surgical interventions. Neuromodulation. 2013;16:10.
  4. VNS therapy system — P970003s050. U.S. Food and Drug Administration. Accessed Nov. 3, 2015.
  5. Vagus nerve stimulation. American Association of Neurosurgeons. Accessed Sept. 3, 2015.
  6. Martin JLR, et al. Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: Variable results based on study designs. European Psychiatry. 2012;27:147.
  7. Britton JW (expert opinion). Mayo Clinic, Rochester, Minn. Nov. 3, 2015.
  8. Seizures and epilepsy: Hope through research. National Institute of Neurological Disorders and Stroke. Accessed Sept. 25, 2014.
  9. Karceski, S., et al. Vagus nerve stimulation for the treatment of epilepsy. Accessed Nov. 3, 2015.
  10. Holtzheimer, PE, et al. Unipolar depression in adults: Treatment with surgical approaches. Accessed Nov. 3, 2015.
  11. Yuan, H, et al. Vagus nerve and vagus nerve stimulation, a comprehensive review: Part II. Headache. In press. Accessed Nov. 3, 2015.